CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 276 enrolled
Drug / intervention
comparison of screening methods +3 moreprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01946139
NCT01946139N/ACompleted
CompareCT.gov

Screening HIV-Infected Women for Anal Cancer Precursors

AIDS Malignancy Consortium·interventional·Posted Sep 19, 2013·Updated Nov 7, 2023

In Brief

A clinical study evaluating comparison of screening methods, laboratory biomarker analysis, and 2 other interventions for Anal Cancer and 2 related conditions. Completed, enrolled 276 participants across 12 sites in 2 countries.

Detailed Summary

This clinical trial studies anal human papillomavirus (HPV) tests in screening for cell changes in the anus in patients with human immunodeficiency virus (HIV). Screening tests may help doctors find cancer cells early and plan better treatment for anal cancer. Completing multiple screening tests may help find the best method for detecting cell changes in the anus.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAnal Cancer, HIV Infection, Human Papilloma Virus Infection
CountriesPuerto Rico, United States
CollaboratorsNational Cancer Institute (NCI)

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedSep 19, 2013
Enrollment StartDec 4, 2013
Primary CompletionOct 31, 2018
TodayJul 2, 2026
Enrollment to primary: 4.9 yearsPosted 12.8 years ago

Interventions

comparison of screening methodsprocedure

Undergo HPV screening using HC2, APTIMA and OncoHealth HPV E6/E7 assays

laboratory biomarker analysisother

Correlative studies

questionnaire administrationother

Ancillary studies

quality-of-life assessmentprocedure

Ancillary studies